Increasing kidney cancer incidence and survival in Estonia: role of age and stage

被引:10
作者
Innos, Kaire [1 ]
Sepp, Teesi [2 ]
Baburin, Aleksei [1 ]
Kotsar, Andres [2 ]
Lang, Katrin [3 ]
Padrik, Peeter [4 ,5 ]
Aareleid, Tiiu [1 ]
机构
[1] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Hiiu 42, EE-11619 Tallinn, Estonia
[2] Tartu Univ Hosp, Surg Clin, Dept Urol & Kidney Transplantat, Tartu, Estonia
[3] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia
[4] Tartu Univ Hosp, Clin Haematol & Oncol, Tartu, Estonia
[5] Univ Tartu, Inst Clin Med, Tartu, Estonia
关键词
RENAL-CELL CARCINOMA; INTERFERON-ALPHA; NORDIC COUNTRIES; BLOOD-PRESSURE; TRENDS; POPULATION; HYPERTENSION; METAANALYSIS; PREVALENCE; RISK;
D O I
10.1080/0284186X.2018.1512158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Kidney cancer rates in Estonia are high. The study aimed to examine long-term trends in kidney cancer incidence, mortality and survival in Estonia, with special focus on age, birth cohorts, morphology and TNM stage.Material and methods: Estonian Cancer Registry provided data on all incident cases of kidney cancer (ICD-10 C64), diagnosed in adults (age 15 years) in Estonia during 1995-2014. Relative survival ratios (RSR) were calculated and excess hazard ratios of dying were estimated with gender, age, period of diagnosis and TNM stage as independent variables. Joinpoint regression modeling was used to calculate estimated annual percentage change for incidence (1970-2014) and mortality (1995-2016) trends. Age-specific incidence rates were presented by birth cohort and period of diagnosis.Results: Incidence increased significantly in both sexes, with the steepest rise seen for localized cancer. Cohort effects were pronounced particularly in men, while period effects were seen from the mid-1980s to mid-1990s in both sexes. Age-standardized five-year RSR for total kidney cancer increased by 13 percentage units (from 53% to 65%) over the study period; the increase was larger for renal cell carcinoma (from 63% to 78%). Survival increases of about five percentage units were seen for stages I/II and III. Age and gender were not associated with excess risk of dying from renal cell carcinoma after adjusting for stage.Conclusion: Estonia is currently among countries with the highest incidence of kidney cancer. The results suggest a combined effect of changing risk profiles in successive birth cohorts and increasing diagnostic activity around 1990. Large survival increase can mostly be attributed to earlier detection, but improved diagnosis and treatment have probably influenced stage-specific survival. High proportion of tumors with unspecified morphology and those with unknown stage among the elderly warrants further investigation of diagnostic and treatment practices.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 51 条
  • [31] International Agency for Research on Cancer, 2018, WHO MORT DAT
  • [32] Prevalence of cardiovascular disease risk factors in Tallinn, Estonia
    Kaldmae, Margit
    Zemtsovskaja, Galina
    Abina, Jelena
    Land, Tiit
    Viigimaa, Margus
    [J]. MEDICINA-LITHUANIA, 2017, 53 (04): : 268 - 276
  • [33] Prevalence and determinants of hypertension in Estonian adults
    Kaldmaee, Margit
    Viigimaa, Margus
    Zemtsovskaja, Galina
    Kaart, Tanel
    Abina, Jelena
    Annuk, Margus
    [J]. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2014, 42 (06) : 504 - 510
  • [34] Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5
    Marcos-Gragera, Rafael
    Mallone, Sandra
    Kiemeney, Lambertus A.
    Vilardell, Loreto
    Malats, Nuria
    Allory, Yves
    Sant, Milena
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (15) : 2217 - 2230
  • [35] Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.2002.20.1.289
  • [36] Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Pili, Roberto
    Bjarnason, Georg A.
    Garcia-del-Muro, Xavier
    Sosman, Jeffrey A.
    Solska, Ewa
    Wilding, George
    Thompson, John A.
    Kim, Sindy T.
    Chen, Isan
    Huang, Xin
    Figlin, Robert A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : 3584 - 3590
  • [37] National Institute for Health Development, 2018, HLTH STAT HLTH RES D
  • [38] Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)
    Nisen, Harry
    Jarvinen, Petrus
    Fovaeus, Magnus
    Gudmundsson, Eirikur
    Kromann-Andersen, Bjarne
    Ljungberg, Borje
    Lund, Lars
    Nilsen, Frode
    Sundqvist, Pernilla
    Beisland, Christian
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (05) : 360 - 366
  • [39] OECD, 2018, HLTH GLANC 2017 OECD
  • [40] Changes in the natural history of renal cancer:: comparison of Estonian data from the periods 1986-1988 and 1996-1998
    Padrik, Peeter
    Kirsimagi, Ulle
    Everaus, Hele
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (01) : 35 - 41